Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 1998, p. 5818-5827, Vol. 18, No. 10
Eukaryotic Transcription Laboratory,
Received 17 December 1997/Returned for modification 5 February
1998/Accepted 28 July 1998
Perhaps the best characterized example of an activator-induced
chromatin transition is found in the activation of the
Saccharomyces cerevisiae acid phosphatase gene
PHO5 by the basic helix-loop-helix (bHLH) transcription
factor Pho4. Transcription activation of the PHO5 promoter
by Pho4 is accompanied by the remodeling of four positioned nucleosomes
which is dependent on the Pho4 activation domain but independent of
transcription initiation. Whether the requirements for transcription
activation through the TATA sequence are different from those necessary
for the chromatin transition remains a major outstanding question. In
an attempt to understand better the ability of Pho4 to activate
transcription and to remodel chromatin, we have initiated a detailed
characterization of the Pho4 activation domain. Using both deletion and
point mutational analysis, we have defined residues between positions
75 and 99 as being both essential and sufficient to mediate
transcription activation. Significantly, there is a marked concordance
between the ability of mutations in the Pho4 activation domain to
induce chromatin opening and transcription activation. Interestingly, the requirements for transcription activation within the Pho4 activation domain differ significantly if fused to a heterologous bHLH-leucine zipper DNA-binding domain. The implications for
transcription activation by Pho4 are discussed.
Activation of transcription by
RNA polymerase II (Pol II) can be divided into two steps:
chromatin, which can act to repress transcription, must undergo a
transition to allow access of the polymerase and transcription
activators to the DNA; and a functional preinitiation complex must be
assembled to allow RNA Pol II subsequently to catalyze the formation of
a nascent RNA molecule. There is evidence for activator function at
both stages, with sequence-specific DNA-binding proteins acting both to
modulate chromatin structure and to increase recruitment,
isomerization, or escape of RNA polymerase from a promoter. For the
majority of transcription activators, the DNA-binding and transcription
activation functions are found in separate domains within the same
protein. Yet in contrast to DNA-binding domains which can be grouped
into families based on their structural similarities deduced from
physical and biochemical evidence, the classification of activation
domains is far more rudimentary, being based largely upon the
preponderance of certain amino acids (acidic, glutamine rich, and
proline rich) and reflecting the lack of knowledge about the
relationship between their structure and function.
The acidic activation domains were the first to be identified and are
the most widely studied. Early experiments in which transcriptionally
active proteins were created by fusing random Escherichia
coli DNA fragments to sequences encoding the Gal4 DNA-binding
domain suggested a positive correlation between high net negative
charge and activation potential (29). Moreover, in addition
to the preponderance of acidic residues, this class of activation
domain was predicted to adopt an amphipathic The notion that acidic activators adopt an amphipathic Considerable progress has been made in understanding activator-target
protein interactions required for transcription activation through the
core transcription machinery; much less is known of the requirements
for modulating chromatin structure. Perhaps the best characterized
example of an activator-induced chromatin transition is found in the
activation of the Saccharomyces cerevisiae acid phosphatase
gene PHO5 by the acidic basic helix-loop-helix (bHLH) transcription factor Pho4, which can bind to two sites within the
PHO5 upstream activating sequence (UAS), termed UASp1 and UASp2. The PHO5 gene is highly expressed under low-phosphate
conditions and is repressed under high-phosphate conditions. Under
high-phosphate conditions, the PHO5 promoter is masked by
four precisely positioned nucleosomes with the exception of a
nuclease-hypersensitive site located over the upstream Pho4 binding
site, UASp1 (1, 13, 44). Under repressing conditions, the
Pho4 activator fails to bind either UASp1 or UASp2, despite the fact
that UASp1 is not concealed by the positioned nucleosomes. In addition,
the activation domain of Pho4 is masked by the Pho80-Pho85 cyclin-cdk
complex (18, 22), which also phosphorylates Pho4
(23), resulting in a proportion of Pho4 being located in the
cytoplasm (33). On switching to low-phosphate conditions,
the Pho80-Pho85 cyclin-cdk complex dissociates from Pho4 (18,
23), unmasking the activation domain and allowing Pho4 to
associate with the homeobox factor Pho2. The Pho4-Pho2 complex then
binds and activates the PHO5 UAS elements cooperatively
(4, 5, 18, 37). As a consequence of Pho4-Pho2 binding to the
PHO5 promoter, the four positioned nucleosomes undergo a
transition, resulting in the entire promoter becoming nuclease
sensitive and Pho4 being bound to both UAS elements. Neither DNA
replication nor transcription directed by the PHO5 TATA
element are required for the chromatin transition (14, 36).
Importantly, however, the Pho4 activation domain is necessary for the
chromatin transition to occur (38). Whether the requirements for transcription activation are different from those necessary for the
chromatin transition remains a major outstanding question.
In an attempt to understand better the ability of Pho4 to activate
transcription and remodel chromatin, we have initiated a detailed
characterization of the Pho4 activation domain. Using both deletion and
point mutational analysis, we have defined residues between positions
75 and 99 as being both essential and sufficient to mediate
transcription activation and demonstrate that the requirements for
transcription activation are dependent on the nature of the DNA-binding
domain. Point mutations and CD analysis revealed that the N-terminal
part of the activation domain may adopt an Genetic and biochemical methods.
The S. cerevisiae strain Y704 (a ade2-1 trp1-1
canR leu2-3 leu2-112 his 3-11,15 ura3
pho4::HIS3) has been described previously (15,
22), as has strain YS33 ( Anti-Pho4 antibody and Western blotting.
Pho4 amino acids
108 to 245 were expressed in E. coli as an in-frame fusion
with glutathione S-transferase (GST). After purification on
glutathione beads, 100 µg of the GST-Pho4 fusion protein was used to
inject rabbits four times at intervals of 1 month. Anti-GST antibodies
were removed from the resulting antiserum by incubation with an excess
GST protein bound to glutathione-Sepharose beads for 2 h at 4°C.
The resulting supernatant was used to probe Western blots for Pho4
expression. Samples for Western blotting were prepared by harvesting
yeast cells grown under appropriate conditions by centrifugation,
resuspending the pellet in sodium dodecyl sulfate (SDS) lysis buffer,
and boiling for 5 min before analysis by SDS-polyacrylamide gel
electrophoresis. Following electrophoresis, proteins were transferred
to a nitrocellulose membrane, blocked in a buffer containing 5% nonfat
milk, and probed with anti-Pho4 antibody for 1 h. After the blots
were washed, they were incubated with an anti-rabbit horseradish
peroxidase-conjugated secondary antibody and washed extensively, and
bands were revealed by using ECL (Amersham) according to the
manufacturer's instructions.
Yeast vectors.
The LexA operator-LacZ reporter has been
described previously (22), as have the LexA-fusion protein
expression vector and the low-copy-number galactose-inducible Pho4
expression vector, pRS315.KV (18). The Pho4 promoter vector
has also been described (38). Pho4 deletion mutants and
point mutations introduced into the Pho4-Cpf1 background were made by
PCR by using appropriate primers which place BamHI
restriction sites at the 5' and 3' ends of the coding sequence. The
construction of the wild-type (WT) Pho4-Cpf1 fusion was described by
Jayaraman et al. (22), and this fusion contains an
engineered XhoI restriction site at the junction between the
Pho4 and Cpf1 coding sequences. All mutations were verified by
sequencing.
CD analysis.
CD spectra were recorded in 10 mM phosphate
buffer with a Jasco J-600 spectrophopolarimeter with peptide
concentrations of 30 to 50 µM (1-mm path length, fused-silica
cuvettes). Spectra are presented as the CD absorption coefficient
calculated on a per-residue basis ( Defining the Pho4 activation domain.
The Pho4
transcription factor comprises a 312-amino-acid protein with a
bHLH DNA-binding domain located within the C-terminal 60 amino acids
(Fig. 1A). Although previous work has
located residues required for transcription activation N-terminal
to either position 108 (31) or 118 (22),
the results from these studies were inconsistent. Thus, in the
exhaustive study of Ogawa and Oshina (31), several regions
within the N-terminal 108 amino acids of Pho4 appeared to play a
significant role in the ability of Pho4 to activate transcription from
the PHO5 promoter. In contrast, Jayaraman et al.
(22), using chimeric constructs, failed to identify any
requirements for transcription activation N-terminal to amino acid 75. A second region of Pho4 required for transcriptional activation resides
between residues 203 and 227 and was termed the oligomerization domain
(31). We subsequently identified this region as being
essential for interaction and cooperative binding with the Pho2
homeodomain transcription factor (5, 18). As a first step
towards understanding the precise requirements for transcription
activation by Pho4, we reexamined the boundaries of the activation
domain.
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Requirements for Chromatin Modulation and
Transcription Activation by the Pho4 Acidic Activation Domain

![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-helical conformation,
a prediction apparently supported by the construction of an artificial
activator (Gal-AH) comprising a 15-amino-acid peptide predicted to form
such a structure, fused to the Gal4 DNA-binding domain (17).
However, in contrast to many other activators, Gal-AH activates poorly
unless overexpressed (26) despite apparently having the
potential to adopt an
-helical conformation as determined by
circular dichroism (CD) analysis (42). Similarly, while the
VP16 activation domain has been predicted to adopt an
-helical
conformation, evidence from CD analysis as well as nuclear magnetic
resonance (NMR) spectroscopy indicates that it is unstructured in an
aqueous solution (11, 32). On the other hand, NMR studies
using a minimal VP16 activation domain suggested that it may adopt an
-helical conformation on interaction with hTAF31 (41),
and, along similar lines, NMR studies have also demonstrated that the
activation domain of the cyclic AMP-responsive transcription factor
CREB undertakes a random coil-to-helix transition on interaction with
the CBP cofactor (34).
-helical
conformation was challenged by CD and mutational analysis of the Gal4
activation domain, which showed that it had the potential to form a
-sheet but not an
-helix (26, 42) and that mutagenesis of the Gal4 activation domain could result in an activating mutant with
a net positive charge (26). However, results from Wu et al.
(45) obtained by using a combination of mutagenesis and surface plasmon resonance have suggested that while the Gal4 activation domain can interact with TBP and TFIIB, the putative
-sheet in the
Gal4 activation domain cannot be required for activation. The concept
of a role for acidic residues in the activation process has been
further undermined by the observation that mutation of hydrophobic
residues in the VP16 activation domain abolishes function even when
substitution increases the overall net negative charge (9,
35), while in the Gcn4 transcription factor, bulky hydrophobic residues appear to make a critical contribution to the activation function (12, 20). In summary, despite recent advances, how transcription factors achieve the level of specificity required to
target different components of the transcription machinery remains
poorly understood.
-helical structure and
that activation has a requirement for aromatic residues. Significantly,
there is a marked concordance between the effects of mutations in the
Pho4 activation domain on chromatin opening and on transcription
activation.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
canR leu2-3
leu2-112 his 3-15 ura3
5
pho4::ura3
5
pho80::HIS3) (31). Cells were grown and
assayed for acid phosphatase activity produced by the PHO5
gene as described previously (38).
-Galactosidase activity was assayed as described previously (18). The
values for the
-galactosidase and acid phosphatase assays using the N-terminal and deletion mutants are presented as averages of three independent experiments, each performed in duplicate. The standard deviations calculated for these data were no more than ±10%. All methods for the ClaI accessibility assays have also been
described previously (2, 16).

mrw).
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (17K):
[in a new window]
FIG. 1.
Defining the Pho4 activation domain. (A) Schematic
diagram of the domains of Pho4 as determined by Hirst et al.
(18). The repression domains RD1 and RD2 are required for
interaction with the Pho80 cyclin, while the Pho2-interacting sequence
(PIS) mediates interaction and cooperative DNA binding with Pho2. (B)
Activity of a series of Pho4 N-terminal deletion mutants. The indicated
mutants were expressed from the GAL10 promoter on a CEN/ARS
vector following transformation into strain Y704, which lacks
endogenous Pho4. Yeast cells were assayed for acid phosphatase (A/Pase)
activity as described previously (38) after induction of
Pho4 expression by growth in low-phosphate galactose medium. The level
of activation achieved by expression of Pho4 under these conditions is
around 60 to 70% of that obtained with endogenous Pho4 in a WT strain
under low-phosphate conditions. Results of the acid phosphatase assays
using the N-terminal and deletion mutants are presented as an average
of three independent experiments, each performed in duplicate. (C)
Activity of a series of Pho4 internal deletion mutants. The indicated
Pho4 internal deletion mutants were expressed from the PHO4
promoter after transformation of yeast strain YS33 (39),
which is deleted for the chromosomal PHO4 and
PHO80 genes. Acid phosphatase assays were performed after
culture in high-phosphate glucose medium.
N75) resulted in no significant reduction
in acid phosphatase levels. In contrast, removal of an additional eight
amino acids (
N83) reduced expression around 70% compared to that of
the WT protein, while a further deletion to amino acid 93 (
N93)
activated transcription around 10-fold less efficiently than the
full-length protein. A similar level of transcription activation was
also observed with the
N108 mutant, which lacks all residues
N-terminal to position 108. These results would indicate that amino
acids located between amino acids 75 and 93 are essential for the
function of the Pho4 activation domain.
12-75,
12-79,
12-83, and
12-93 were in good
agreement with those obtained with the N-terminal deletion series. That
is, residues 83 to 93 were essential for efficient transcription
activation. Consistent with this, removal of residues 79 to 99 failed
to activate transcription above the background observed when the
N108 mutant was used. Activation of around 40 to 50% of that
observed with WT Pho4 was observed with mutants
79-90 and
87-99,
indicating that the regions lying between positions 79 and 87, or 90 and 99, may each contribute to transcription activation. In contrast,
no significant effect on the transactivation capacity of Pho4 was
detected with mutant
97-106 or
101-110, indicating that sequences
C-terminal to amino acid 97 are not required. In summary, the
N-terminal and internal deletion mutants identify a critical region of
Pho4 lying between amino acids 79 and 99, which play an essential role
in transcription activation by Pho4.
Modulation of chromatin by the Pho4 activation domain. Under repressing, high-phosphate, conditions, the PHO5 promoter is packaged into an array of four positioned nucleosomes. Upon switching to low-phosphate conditions, the chromatin covering the PHO5 promoter is remodeled, resulting in a 600-bp region of the promoter becoming hypersensitive to nuclease digestion. This chromatin transition is dependent on Pho4 binding to the PHO5 UAS elements and, importantly, is dependent on the Pho4 activation domain (38). However, although the activation domain of Pho4 is required, the alterations in chromatin structure appear to be independent of transcription initiation, since the Pho4-induced chromatin transition occurs even when the PHO5 TATA box has been mutated (14). Having identified residues essential for transcription activation by Pho4, we were now in a position to address a major outstanding question concerning the ability of Pho4 to remodel chromatin, namely, are the requirements within the Pho4 activation domain for transcription initiation different from those required to induce the chromatin transition? In other words, would it be possible to identify activation domain mutations that induced an efficient chromatin transition but which would not support transcription initiation?
To this end, yeast strain YS33, which lacks both endogenous Pho4 and the repressor Pho80, were transformed with vectors constitutively expressing the series of Pho4 internal deletion mutants and their ability to induce the chromatin transition at the PHO5 promoter was assessed. To assay chromatin disruption at the PHO5 promoter, we isolated yeast nuclei and measured the accessibility of a ClaI site located within positioned nucleosome
2. Although in principle the ability of a specific
restriction endonuclease to cut a particular site might reflect only a
localized remodeling of chromatin, the ability of ClaI to
cut this site within the PHO5 promoter is a reliable and
quantitative assay that has been used previously by us (for examples,
see references 2, 16, 36, and 44) to provide an accurate reflection of whether the chromatin across the
entire PHO5 promoter is in a closed or open conformation. A
map of the PHO5 promoter and the relative positions of the
four positioned nucleosomes and the ClaI site used for the
chromatin opening assays is shown in Fig.
2A, while the results of the
ClaI accessibility assays are presented in Fig. 2B and C.
|
12-83, which
lacks an additional four amino acids, was also able to open chromatin
to 70%. However, Pho4 deleted between amino acids 12 and 93 failed to
open chromatin to any significant extent (10%). A similar low level of
ClaI accessibility was also observed with mutant
79-99,
indicating that this region contains residues critical for chromatin
modulation. Compared to the
79-99 mutant, the presence of residues
91 to 99 (
79-90) restores activity to around 50%, as does the
presence of residues 79 to 86 (
87-99). No significant effect of
deletion of residues 97 to 106 or 101 to 110 was observed in the
ClaI accessibility assay. Taken together, these results
indicate that residues essential for chromatin opening lie between
amino acids 79 and 99. A comparison of results from the induction of
acid phosphatase expression with those of the ClaI
accessibility assay are strikingly concordant; residues essential for
induction of the chromatin transition appear to correlate well with
those required for transcription activation.
The minimal Pho4 activation domain. The results described above indicate, first, that residues 79 to 99 are essential for transcription activation and, second, that this region of Pho4 is required both for transcription of the acid phosphatase gene and for modulation of the chromatin located across the PHO5 promoter. However, while the mutants used so far define residues essential for these functions, the question as to whether this region is sufficient remains outstanding.
To address this point, full-length Pho4 or C-terminal deletion mutants were expressed as fusions with the bacterial LexA repressor. Fusion to LexA was necessary since C-terminal deletions disrupt the bHLH DNA-binding domain located at the C terminus of Pho4. The results obtained (Fig. 3) by using the Lex-Pho4 fusions and a LacZ reporter driven by the Lex operator show that a deletion removing residues C-terminal to amino acid 162 (
C162)
activates transcription to WT levels. Similar results were obtained
when only the N-terminal 108 amino acids of Pho4 (
C108) were fused to LexA. Removal of additional residues in mutant
C93 also failed to
affect significantly the ability of the chimeric LexA-Pho4 protein to
activate transcription. In contrast, further deletion to amino acid 83 (
C83) largely abolished the transactivation capacity. Thus,
consistent with the N-terminal and internal deletion series, the region
lying between amino acids 83 and 93 is essential for transcription
activation.
|
Requirements for transcription activation within the Pho4
activation domain are dependent on the DNA-binding domain.
The
region of Pho4 between amino acids 75 and 99 contains residues which
are both necessary and sufficient for transcription activation. We have
previously suggested that the region of Pho4 between residues 74 and 85 may have the potential to form an acidic amphipathic
-helix
(22). For other transcription factors, structural studies
have demonstrated a key role for
-helices in mediating the
interaction between transcription factors and their target proteins
(24, 34, 41). However, the Pho4 N-terminal deletion series
(Fig. 1) failed to reveal a critical role for residues 75 to 83 in
transcription activation by Pho4, perhaps owing to redundancy within
the activation domain. To circumvent this problem, we made use of the
observation that if the Pho4 DNA-binding domain were replaced with that
from the yeast bHLH-leucine zipper (LZ) factor Cpf1 (3, 6,
30), the chimeric protein retained the capacity to bind the
endogenous PHO5 UAS elements, but transcription activation
by the Pho4-Cpf1 fusion protein, depicted in Fig.
4A, was significantly more sensitive to
mutation. The increased sensitivity of a Pho4-Cpf1 chimeric protein to
deletions within the activation domain is illustrated in Fig. 4B; for
this experiment, a series of N-terminal deletion mutants were
constructed and assayed for their ability to activate the endogenous
PHO5 acid phosphatase gene under low-phosphate conditions in
a strain lacking the endogenous Pho4 protein. The results obtained show
that deletion to amino acid 75 (
N75) resulted in no more than a 20%
reduction in acid phosphatase levels. In contrast, removal of an
additional eight amino acids (
N83) reduced expression around 10-fold
compared to that of the WT Pho4-Cpf1 protein, while a further deletion to amino acid 93 (
N93) failed to activate transcription to a measurable extent. A similar inability to activate transcription was
also observed with the
N108 mutant, which lacks all residues N-terminal to position 108. These results are consistent with those
obtained with the WT Pho4 protein, with the exception that the effects
of the
N83 and
N93 mutations are significantly more severe than
those in the background of the homologous Pho4 DNA-binding domain
(compare Fig. 4B and 1B). Since the
N75 and
N83 Pho4-Cpf1 proteins were expressed to similar levels, as determined by Western blotting (data not shown), in the context of the Cpf1 DNA-binding domain, effective activation of transcription by Pho4 appeared to
require residues which corresponded to the predicted
-helical region, whereas in the context of the natural Pho4 DNA-binding domain,
these residues played a relatively minor role.
|
12-75,
12-83, and
12-93 were assayed for their ability to open chromatin
across the PHO5 promoter by using the ClaI
accessibility assay. The results obtained (Fig. 4C) revealed that the
12-75 deletion mutant could open chromatin to 95%, while
ClaI accessibility with either the
12-83 or
12-93
deletion mutant was no more than 10%. Taken together with the results
described above, it is evident that the region of Pho4 lying between
residues 75 and 83 plays a critical role in transcription activation
and chromatin opening in the context of the Pho4-Cpf1 chimera but not
when fused to the natural Pho4 DNA-binding domain. Thus, the
requirements for transcription activation and chromatin modulation are
dependent on the nature of the DNA-binding domain.
Requirements for specific amino acids in activation and chromatin
opening by Pho4.
The results obtained by using the Pho4-Cpf1
chimeras revealed that the region of Pho4 between residues 75 and 83 was able to play a critical role in both transcription activation and
chromatin opening, while in the context of Pho4 itself, the region
between residues 75 and 83 was far less important but the region
between residues 83 and 93 was essential. Consistent with the reduced sensitivity of Pho4 to mutation, single amino acid substitutions in the
context of Pho4 itself (D78A, D78P, D90A, M92A) failed to affect
transcription activation more than twofold (data not shown), most
likely owing to redundancy within the activation domain. However, the
increased sensitivity of the Pho4-Cpf1 chimera to mutation provided us
with an opportunity to explore the specific amino acid requirements
within the activation domain. In particular, we wished to determine
which residues might contribute to transcription activation and, also,
whether evidence from a mutational analysis could lend support to the
idea that the region between residues 75 and 83 of Pho4 could adopt an
-helical conformation. The sequence of the Pho4 activation domain
and the location of the potential
-helix are shown in Fig.
5A, and a helical wheel
analysis (Fig. 5B) illustrates that within the potential amphipathic
-helix, all charged or hydrophilic residues are located on one face
while all hydrophobic residues are on the opposite face.
|
N75 Pho4-Cpf1 fusion protein in
anticipation that in this background the effects of single point
mutations would be evident. In both the VP16 and Gcn4 activation domains, aromatic amino acids play a crucial role (9, 12, 20,
35). In Pho4, a single aromatic residue, F81, lies within the
potential
-helix. To determine whether this phenylalanine was
important for transcription activation, it was mutated to alanine.
Introduction of an alanine would be expected to maintain any potential
-helix while abolishing any interaction dependent on the aromatic
nature of the phenylalanine side chain. Compared to the
N75
Pho4-Cpf1 derivative, the F81A substitution reduced activity around
five- to sixfold (Fig. 5C), despite being expressed to similar levels
as determined by Western blotting (Fig. 5E), suggesting that F81 is
essential for the full activity of the Pho4 activation domain. In
contrast, replacement of F81 with either tryptophan or tyrosine, which
like phenylalanine have aromatic side chains, had little effect on
transcription activation, acid phosphatase activities being,
respectively, 90 and 71% of that obtained with the parental
N75
protein. These data indicate that either an aromatic side chain or
possibly a bulky hydrophobic residue at position 81 plays a crucial
role in the transactivation function.
The region of the Pho4 activation domain containing F81 is predicted to
adopt an
-helical conformation. Introduction of a proline residue
into this region of Pho4 would most likely disrupt any
-helix and,
if an
-helical conformation were important for function, might also
be expected to reduce the ability of Pho4-Cpf1 to activate
transcription. To test this, we replaced F81 with proline and assayed
for the ability of the F81P mutant to activate expression of the
PHO5 gene. Consistent with the
-helix being important for
function, the F81P mutant activated transcription around sevenfold less
well than the parental
N75 protein (Fig. 5C) but was expressed to a
similar level (Fig. 5E). However, activation by the F81P mutant was not
significantly less than that obtained for the F81A mutant, and it could
be argued that the sevenfold reduction in activation observed with the
F81P mutant simply reflected an absence of an aromatic or large
hydrophobic side chain at this position rather than disruption of an
-helix. To distinguish between these possibilities, it was necessary
to find residues whose replacement by alanine would not affect the
ability to activate transcription.
Our initial attention focused on mutation of the aspartic acid residue
at position 78, located on the hydrophilic face within the core of the
potential
-helix. Given the key role played by hydrophobic residues
in the activation process, it is possible that acidic residues may
serve simply to provide a hydrophilic face to the amphipathic helix
rather than participating directly in protein-protein interactions.
Consistent with this, mutation of D78 to alanine (D78A) failed to
decrease the ability of Pho4 to activate transcription and in fact
increased the potential for activation around 1.5-fold (Fig. 5C). Since
the nature of the amino acid side chain at position 78 did not appear
to be a significant factor in determining the capacity for
transcription activation, we also introduced a proline residue in the
same position. In contrast to the D78A mutation, the D78P mutant
activated transcription more than 12-fold less well than the parental
N75 protein (Fig. 5C) but was expressed at a level similar to those
of the WT and D78A mutant (Fig. 5E). This result is consistent with the
region between residues 75 and 85 adopting an
-helical conformation and the
-helix being required for transcription activation.
We also introduced an alanine and proline substitution for leucine at
position 77. However, although the L77A mutant activated transcription
to almost-WT levels (70%) (Fig. 5C) and was expressed well (Fig. 5E),
the substitution with a proline residue at this position resulted in a
protein which was poorly expressed as assessed by Western blotting
(data not shown) and as such no meaningful information could be gained
from the use of the L77P mutant.
The C-terminal half of the Pho4 activation domain between amino acids
87 and 93 is highly methionine rich (Fig. 5A), but despite the presence
of two aspartic acid residues at positions 88 and 90, it is not
predicted to adopt an
-helical conformation. Nevertheless, this
region may be structured in the context of Pho4, and the results from
the initial deletion analysis in the context of both Pho4 and LexA
implicated this region in transcription activation by Pho4. In an
attempt to identify key residues within this region of the activation
domain, single alanine substitutions were introduced at each position
and the resulting mutants were assayed for their ability to activate
PHO5 expression. In particular, given the importance of
aromatic residues in transcription activation, we wished to address the
contribution of the tryptophan at position 91. The results are shown in
Fig. 5D. Mutation of W91 to alanine (W91A) reduced activation of
PHO5 fourfold. In contrast, activation was reduced no more
than 2.5-fold by introduction of alanines at any of the other six
positions, with all proteins being expressed to similar levels (Fig.
5E).
With the exception of W91, the substitution across this region with
alanine residues for D88, M89, D90, M92, and M93 failed to dramatically
affect the function of the Pho4 transcription activation domain. It was
possible, however, that alanines might represent a relatively
conservative substitution which, while altering the nature of the amino
acid side chains present in this region of Pho4, might nevertheless
enable any secondary structure to be conserved. In an attempt to
address this possibility, we introduced a glycine residue at position
90. While substitution with alanine at this position resulted in a
maximum decrease of Pho4 activity of 2.5-fold, substitution with
glycine for aspartic acid at position 90 (D90G mutant) resulted in a
10-fold decrease in PHO5 activity. However, Western blotting
(Fig. 5E) revealed that while the D90G mutant was expressed, it was not
possible to know whether its slightly faster migration when analyzed by SDS-polyacrylamide gel electrophoresis was caused by an altered conformation or whether it resulted from the removal of a few amino
acids by proteolysis. An M92G mutant was poorly expressed (data not
shown) and consequently the impact of this mutation on transcription
activation could not be assessed.
One of our primary aims in this study was to examine whether mutations
within the Pho4 activation domain could be used to separate chromatin
opening from transcription activation. The deletion analysis of both
Pho4 and the Pho4-Cpf1 chimeric proteins indicated that the two
functions were closely linked. To investigate further the requirements
for chromatin opening, we also examined three specific point mutations
for their ability to modulate chromatin across the PHO5
promoter by using the ClaI accessibility assay. The results
are shown in Fig. 5F. Mutant D78A, which was able to activate
transcription to WT levels, opened chromatin to around 95%. By
contrast, the D78P mutant, which was severely impaired in its ability
to activate transcription, failed to open chromatin to more than 15%,
and the D90A mutant, which activated PHO5 expression to
intermediate levels, between 30 and 45% of that of the WT in different
experiments, exhibited an intermediate degree of ClaI accessibility, around 25%. Although we have not tested the entire series of point mutations in the chromatin opening assay, we have yet
to find an example by using either the point mutants or the deletion
mutants with which efficient chromatin opening was achieved in the
absence of transcription activation.
CD analysis of the Pho4 activation domain.
The data described
so far would indicate that the Pho4 activation domain comprises
residues located between positions 75 and 99, with both the
secondary-structure predictions and the mutagenesis indicating that the
N-terminal part of this region may adopt an
-helical conformation
which contributes to efficient transcription activation. In an attempt
to confirm the existence of the potential
-helix, we subjected
peptides (Fig. 6A) corresponding to the WT Pho4 activation domain extending from residues 69 to 94 and the D78A
and D78P mutants to CD analysis, a technique used to identify secondary
structure in proteins and peptides as well as in DNA polymers. The D78A
and D78P mutants were chosen since the D78A mutation, which would not
be expected to affect any potential
-helical structure, does not
reduce the ability of Pho4 to activate transcription while the D78P
mutation, which would disrupt any
-helix, severely affects
transcription activation. CD analysis was performed with the peptides
in either an aqueous buffer or in the presence of 50%
trifluoroethylene (TFE), a dehydrating solvent which by providing a
less polar environment is useful to reveal hidden structural
propensities (for examples, see references 21 and
28). For the WT peptide in aqueous buffer, the
marked trough at 197 nm indicates that the peptide is conformationally mobile and, together with the signal at 220 nm, indicates a lack of any
significant
-helical content. Similar results have been obtained
with a peptide known to adopt an amphipathic
-helical structure
(10) and with the activation domains from VP16
(11), CREB (19), and NF-
B (25). By
contrast, the same peptide in 50% TFE exhibits a marked decrease in

at 220 nm, consistent with the ca. 30 to 40% of the peptide
adopting an
-helical structure. Given that the peptide contains not
only the N-terminal
-helical region located between residues 73 and
83 but also residues 84 to 94, which are not expected to participate in
any
-helix, we would not anticipate that the WT peptide would in any
event contain greater than 50%
-helical structure. A similar result
is obtained with a corresponding peptide containing the D78A mutation.
In this case, in the presence of 50% TFE, this mutation results again in around 30 to 40%
-helical content, as indicated by the spectrum at 220 nm. By contrast, the
-helical content of the peptide
containing the D78P mutation is markedly decreased, to around 10%,
with no difference being observed in the value at 220 nm in the
presence or absence of TFE. In addition, a peptide extending from amino acids 83 to 106, which lacks the potential
-helical region, failed to reveal any
-helical structure in the presence or absence of TFE
(data not shown). The CD analysis is therefore consistent with the
N-terminal region of the Pho4 activation domain adopting an
-helical
conformation and with the presence of the
-helix in the WT and D78A
peptides correlating with the ability of the activation domain to
activate transcription.
|
| |
DISCUSSION |
|---|
|
|
|---|
Chromatin plays a major role in the regulation of gene expression. Thus, for a gene to be transcribed, the chromatin assembled across a promoter must adopt a conformation compatible with RNA polymerase and its accessory factors, gaining access to the promoter and initiating transcription. How the modulation of chromatin conformation is coupled to transcription activation remains a largely unresolved question. The ability of the Pho4 transcription factor to induce a chromatin transition and to activate transcription of the PHO5 promoter has provided one of the best systems for studying the concerted regulation of chromatin structure and transcription, with the disruption of the four nucleosomes positioned across the PHO5 promoter being dependent on the presence of the Pho4 activation domain (38). However, the ability of Pho4 to modulate chromatin does not require transcription initiation since deletion of the TATA box, which prevents transcription initiation, still allows the Pho4-dependent chromatin transition to occur (14). This result led to the notion that nucleosome remodeling across the PHO5 promoter may be a prerequisite for transcription activation mediated by the interaction between the Pho4 activation domain and components of the transcriptional machinery.
In this study, we set out to define the requirements within Pho4 for both transcription activation and chromatin modulation with the joint aims of defining the requirements for activation of transcription by Pho4 and of determining whether the requirements for transactivation and chromatin opening within the activation domain were separable. Using a combination of deletion and point mutations, we were able to demonstrate that residues located between amino acids 75 and 99 were both essential and sufficient to catalyze transcription activation, either in the context of Pho4 or when fused to either the LexA or Cpf1 DNA binding domains. Moreover, the analysis of the chromatin structure across the PHO5 promoter using the ClaI accessibility assay revealed a strong correlation between the ability of Pho4 or its derivatives to open chromatin and to activate transcription. In other words, we were unable to identify mutations that were permissive for chromatin opening but deficient in transcriptional activation. This result raises the possibility that chromatin opening and transcription activation are mediated by a single entity that is recruited by the Pho4 activation domain. One candidate for this dual role is the RNA Pol II holoenzyme itself. Thus, when Gal11, a component of the RNA Pol II holoenzyme, is brought to the DNA as a Pho4-Gal11 fusion protein, it is able both to remodel chromatin and to activate transcription from the PHO5 promoter in the absence of a classical activation domain (16). The conclusion from these experiments was that recruitment of the holoenzyme or its associated factors may be sufficient for chromatin remodeling. However, while chromatin opening may be achieved by the artificial targeting of Gal11 to the DNA and recruitment of RNA Pol II and/or associated factors may be sufficient to remodel chromatin, we appreciate fully that this does not necessarily mean that, in its natural environment, the way Pho4 triggers chromatin disruption is by directly recruiting the RNA Pol II holoenzyme to the PHO5 UAS elements.
An alternative possibility is that the Pho4 activation domain may sequentially recruit factors that either remodel chromatin or activate transcription and that these factors have identical, or at least very similar, requirements for interaction with Pho4. The ability of a single activation domain to target multiple distinct factors would not be unreasonable. For example, the activation domain of p53 mediates transcription activation and is targeted directly by the MDM2 repressor, with residues required for interaction with MDM2 also being required for transcription activation (7, 24, 27). At present, our results do not allow us to distinguish between the possibilities outlined above, but the availability of multiple activation domain mutants will be of use in defining physiologically relevant targets for the Pho4 activation domain.
In the course of the work presented here, we found that the effects of activation domain mutations were more severe in the context of the Pho4-Cpf1 chimeric proteins than in the WT Pho4 background. Although other explanations are possible, we view it as likely that in vivo the Cpf1 DNA-binding domain has a lower affinity for the UASp1 element than the Pho4 DNA-binding domain and that a lower affinity for the target sequence may be compensated for in part by the presence of a stronger activation domain. The relationship between the ability to bind DNA and the strength of the activation domain has been pointed out previously (45), and experiments designed to examine DNA binding in vivo have indicated that proteins with identical DNA-binding domains bind DNA with affinities which reflect the strength of the activation domain (40, 43). Thus, activation and DNA-binding domains will cooperate both for transcription activation and DNA recognition, and mutation or alteration of one domain will affect the efficacy of the other. One practical consequence of this is that the requirements for transcription activation which may be identified by mutational analysis are likely to differ depending on the choice of DNA-binding domain. As such, the interpretation of precisely which residues contribute to the activation process may not be straightforward.
Whatever the reason for the increased sensitivity of the Pho4-Cpf1
chimeras to mutagenesis, we were able to exploit this feature to
analyze the consequences of single point mutations in the Pho4 activation domain. Together with the data obtained from the deletion mutagenesis, the results appear to be consistent with the activation domain of Pho4 comprising two subdomains, each of which contributes to
transcription activation. Although we were unable to obtain any
information concerning the potential structure of the C-terminal subdomain, comprising residues 83 to 99, the N-terminal subdomain, located between amino acids 73 and 83, may adopt an
-helical conformation since introduction of alanine for aspartic acid at position 78 failed to affect transcription while substitution with
proline for aspartic acid at the same position severely reduced activation.
The conclusion from the mutagenesis was substantiated by the CD
analysis of WT and mutant peptides derived from the activation domain.
The results showed that the effect of mutations on the ability of the
peptides to adopt an
-helical conformation reflected the ability of
the same mutations to perturb transcription activation. We note that
the peptide corresponding to the activation domain has a propensity to
form an
-helix only in 50% TFE, a solvent which provide a less
polar environment. Although TFE might be regarded as providing a
nonphysiological environment, the information available on activation
domains from a number of studies indicates that hydrophobic residues
play a key role. Where crystal or NMR structures have been derived from
transcription activation domains complexed with repressors,
coactivators, or TATA-binding protein-associated factors (TAFs),
e.g., p53-MDM2 (24), CREB-CBP (34), or VP16-TAF31 (41), the structures reveal that the key hydrophobic
residues are buried in the interface between the interacting proteins
and, moreover, that the activation domains in solution are
unstructured, adopting an
-helical conformation only on interaction
with their target proteins. Thus, the natural environment for a
functional transcription activation domain is not an aqueous solution
but rather a hydrophobic environment. The purpose of the TFE used in
the CD analysis is therefore to provide a more hydrophobic environment
which may, to some extent, mimic that of the activation domain when
complexed with its target proteins. Indeed, for those activation
domains for which both CD and NMR data are available, there is a
striking concordance between the results obtained by the two
techniques. Thus, for example, the CREB activation domain undergoes a
random coil-to-helix transition on interaction with its target, CBP, as
determined by NMR (34), with CD analysis revealing the same
transition but only in the presence of TFE (19). Similarly,
the random coil-helix transition which occurs in the VP16 activation
domain on interaction with TAF31 (41) can also be reproduced
by using CD analysis (11) but, again, only in the presence
of TFE. Although we are fully aware that results from CD analysis
should not be taken as conclusive proof of structure, the results
obtained are in agreement with the results from the mutagenesis and
together are consistent with the N-terminal region of the activation
domain having a propensity to adopt an
-helical conformation in
vivo, at least when it contacts its appropriate targets.
Although there has long been speculation that activation domains would
adopt an
-helical structure, clear evidence that this may be the
case has been forthcoming only recently, most likely because the
-helical structure appears to be induced only on binding to an
appropriate target, as discussed above. For example, in addition to the
CREB-CBP and VP16-TAF31 interactions, the p53 activation domain adopts
an
-helical conformation when complexed with the MDM2 repressor
(24) and presumably adopts a similar conformation when
interacting with target proteins through which p53 mediates
transcription activation. It seems likely that many activation domains,
including perhaps Pho4, may make use of
-helices to interact with
their targets. It is also likely that other structures may be used and
that activation domains will contain multiple subregions, each able to
contribute to activator-target interactions. In the case of Pho4, the
results from the deletion analysis indicated that regions of residues
91 to 98 and 79 to 86, which are present in mutants
79-90 and
87-99, respectively, each contribute to transcription activation
since although these mutants can both activate transcription well, a
deletion removing residues 79 to 99 is essentially inactive. The Pho4
activation domain is likely therefore to comprise many residues acting
cooperatively to activate transcription, an idea supported by the fact
that double point mutations affect transcription activation to a
considerably greater degree than single point mutations do (data not
shown). However, this should not be taken as evidence that the Pho4
activation domain contacts multiple targets simultaneously. It is
equally possible that at any given moment the Pho4 activation domain
presents an extended surface for contact with a single target but that the interaction is sufficiently robust to tolerate the loss of a subset
of contacts.
Finally, although we have defined specific requirements for transcription activation and chromatin opening on the PHO5 promoter, requirements which presumably reflect the need for Pho4 to interact with or recruit target proteins, it is not evident whether Pho4 or other transcription factors have the same requirements for transcription activation on different promoters. In other words, is it possible that the choice of activator-target protein interactions may be promoter and context dependent? The Pho4 activation domain mutants described here should enable us to address this important question as well as to allow the identification of physiologically relevant targets for the Pho4 activation domain.
| |
ACKNOWLEDGMENTS |
|---|
We thank Gerard Evan for providing the peptides used for the CD analysis and D. Blaschke for expert assistance.
This work was supported by Marie Curie Cancer Care, the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Deutsche Forschungsgemeinschaft (SFB 190), and Fonds der Chemischen Industrie.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Eukaryotic Transcription Laboratory, Marie Curie Research Institute, The Chart, Oxted, Surrey RH8 0TL, United Kingdom. Phone: 44 1883 722306. Fax: 44 1883 730426. E-mail: c.goding{at}mcri.ac.uk.
Present address: Department of Pathology, Washington University
School of Medicine, St. Louis, MO 63110-1093.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Almer, A., and W. Hörz. 1986. Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast. EMBO J. 5:2681-2687[Medline]. |
| 2. | Almer, A., H. Rudolph, A. Hinnen, and W. Hörz. 1986. Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activating DNA elements. EMBO J. 5:2689-2696[Medline]. |
| 3. |
Baker, R. E., and D. C. Masison.
1990.
Isolation of the gene encoding the Saccharomyces cerevisiae centromere-binding protein CP1.
Mol. Cell. Biol.
10:2458-2467 |
| 4. |
Barbaric, S.,
M. Münsterkötter,
J. Svaren, and W. Hörz.
1996.
The homeodomain protein Pho2 and the basic-helix-loop-helix protein Pho4 bind DNA cooperatively at the yeast PHO5 promoter.
Nucleic Acids Res.
24:4479-4486 |
| 5. |
Barbaric, S.,
M. Münsterkötter,
C. Goding, and W. Hörz.
1998.
Cooperative Pho2-Pho4 interactions at the PHO5 promoter facilitate Pho4 binding to UASp1 and enhance transactivation by Pho4 at UASp2.
Mol. Cell. Biol.
18:2629-2639 |
| 6. | Cai, M., and R. W. Davis. 1990. Yeast centromere binding protein CBF1, of the helix-loop-helix protein family, is required for chromosome stability and methionine prototrophy. Cell 61:437-446[Medline]. |
| 7. |
Chang, J.,
D. H. Kim,
S. W. Lee,
K. Y. Choi, and Y. C. Sung.
1995.
Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein.
J. Biol. Chem.
270:25014-25019 |
| 8. | Clark, D. J., C. S. Hill, S. R. Martin, and J. O. Thomas. 1988. Alpha-helix in the carboxy-terminal domains of histones H1 and H5. EMBO J. 7:69-75[Medline]. |
| 9. |
Cress, W. D., and S. J. Triezenberg.
1991.
Critical structural elements of the VP16 transcriptional activation domain.
Science
251:87-90 |
| 10. | Degrado, W. F., F. J. Kedzy, and E. T. Kaiser. 1981. Design, synthesis and characterization of a cytotoxic peptide with melittin-like activity. J. Am. Chem. Soc. 103:679-681. |
| 11. |
Donaldson, L., and J. P. Capone.
1992.
Purification and characterization of the carboxy terminal transactivation domain of Vmw65 from herpes simplex virus.
J. Biol. Chem.
267:1411-1414 |
| 12. | Drysdale, C. M., E. Duenas, B. M. Jackson, U. Ruesser, G. H. Braus, and A. G. Hinnebusch. 1995. The transcriptional activator GCN4 contains multiple activation domains that are critically dependent on hydrophobic amino acids. Mol. Cell. Biol. 15:1220-1233[Abstract]. |
| 13. | Fascher, K. D., J. Schmitz, and W. Hörz. 1990. Role of trans-activating proteins in the generation of active chromatin at the PHO5 promoter in S. cerevisiae. EMBO J. 9:2523-2528[Medline]. |
| 14. | Fascher, K. D., J. Schmitz, and W. Hörz. 1993. Structural and functional requirements for the chromatin transition at the PHO5 promoter in Saccharomyces cerevisiae upon PHO5 activation. J. Mol. Biol. 231:658-667[Medline]. |
| 15. | Fisher, F., P. S. Jayaraman, and C. R. Goding. 1991. C-myc and the yeast transcription factor PHO4 share a common CACGTG-binding motif. Oncogene 6:1099-1104[Medline]. |
| 16. | Gaudreau, L., A. Schmid, D. Blaschke, M. Ptashne, and W. Hörz. 1997. RNA polymerase holoenzyme recruitment is sufficient to remodel chromatin at the yeast PHO5 promoter. Cell 89:55-62[Medline]. |
| 17. | Giniger, E., and M. Ptashne. 1987. Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit. Nature 330:670-672[Medline]. |
| 18. | Hirst, K., F. Fisher, P. C. McAndrew, and C. R. Goding. 1994. The transcription factor, the Cdk, its cyclin and their regulator: directing the transcriptional response to a nutritional signal. EMBO J. 13:5410-5420[Medline]. |
| 19. | Hua, X.-Q., W.-H. Jia, B. P. Bullock, J. F. Habener, and M. A. Weiss. 1998. Transcriptional activator-cofactor recognition: nascent folding of a kinase-inducible transactivation domain predicts its structure on coactivator binding. Biochemistry 37:5858-5866[Medline]. |
| 20. | Jackson, B. M., C. M. Drysdale, K. Natarajan, and A. G. Hinnebusch. 1996. Identification of seven hydrophobic clusters in GCN4 making redundant contributions to transcriptional activation. Mol. Cell. Biol. 16:5557-5571[Abstract]. |
| 21. | Jasanoff, A., and A. R. Fersht. 1994. Quantitation of helical propensities from trifluoroethanol titration curves. Biochemistry 33:2129-2135[Medline]. |
| 22. | Jayaraman, P. S., K. Hirst, and C. R. Goding. 1994. The activation domain of a basic helix-loop-helix protein is masked by repressor interaction with domains distinct from that required for transcription regulation. EMBO J. 13:2192-2199[Medline]. |
| 23. |
Kaffman, A.,
I. Herskowitz,
R. Tjian, and E. K. O'Shea.
1994.
Phosphorylation of the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85.
Science
263:1153-1156 |
| 24. |
Kussie, P. H.,
S. Gorina,
V. Marechal,
B. Elenbaas,
J. Moreau,
A. J. Levine, and N. P. Pavletich.
1996.
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.
Science
274:948-953 |
| 25. |
Leinhard Schmitz, M.,
M. A. dos Santos Silva,
H. Altmann,
M. Czisch,
T. A. Holak, and P. A. Bauerle.
1994.
Structural and functional analysis of the NF- B p65 C terminus.
J. Biol. Chem.
269:25613-25620 |
| 26. | Leuther, K. K., J. M. Salmeron, and S. A. Johnston. 1993. Genetic evidence that an activation domain of GAL4 does not require acidity and may form a beta-sheet. Cell 72:575-585[Medline]. |
| 27. |
Lin, J.,
J. Chen,
B. Elenbaas, and A. J. Levine.
1994.
Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.
Genes Dev.
8:1235-1246 |
| 28. | Luo, P., and R. L. Baldwin. 1997. Mechanism of helix induction by trifluoroethanol: a framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. Biochemistry 36:8413-8421[Medline]. |
| 29. | Ma, J., and M. Ptashne. 1987. A new class of yeast transcriptional activators. Cell 51:113-119[Medline]. |
| 30. | Mellor, J., W. Jiang, M. Funk, J. Rathjen, C. A. Barnes, T. Hinz, J. H. Hegemann, and P. Philippsen. 1990. CPF1, a yeast protein which functions in centromeres and promoters. EMBO J. 9:4017-4026[Medline]. |
| 31. |
Ogawa, N., and Y. Oshima.
1990.
Functional domains of a positive regulatory protein, PHO4, for transcriptional control of the phosphatase regulon in Saccharomyces cerevisiae.
Mol. Cell. Biol.
10:2224-2236 |
| 32. | O'Hare, P., and G. Williams. 1992. Structural studies of the acidic transactivation domain of the Vmw65 protein of herpes simplex virus using 1H NMR. Biochemistry 31:4150-4156[Medline]. |
| 33. | O'Neill, E. M., A. Kaffman, E. R. Jolly, and E. K. O'Shea. 1996. Regulation of PHO4 nuclear localization by the PHO80-PHO85 cyclin-CDK complex. Science 271:209-212[Abstract]. |
| 34. | Radhakrishnan, I., G. C. Perez-Alvarado, D. Parker, H. J. Dyson, M. R. Montminy, and P. E. Wright. 1997. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell 91:741-752[Medline]. |
| 35. |
Regier, J. L.,
F. Shen, and S. J. Triezenberg.
1993.
Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator.
Proc. Natl. Acad. Sci. USA
90:883-887 |
| 36. | Schmid, A., K. D. Fascher, and W. Hörz. 1992. Nucleosome disruption at the yeast PHO5 promoter upon PHO5 induction occurs in the absence of DNA replication. Cell 71:853-864[Medline]. |
| 37. | Shao, D., C. L. Creasy, and L. W. Bergman. 1996. Interaction of Saccharomyces cerevisiae Pho2 with Pho4 increases the accessibility of the activation domain. Mol. Gen. Genet. 251:358-364[Medline]. |
| 38. | Svaren, J., J. Schmitz, and W. Hörz. 1994. The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBO J. 13:4856-4862[Medline]. |
| 39. | Svaren, J., U. Venter, and W. Hörz. 1995. In vivo analysis of nucleosome structure and transcription factor binding in S. cerevisiae. Methods Mol. Genet. 6:153-167. |
| 40. |
Tanaka, M.
1996.
Modulation of promoter occupancy by cooperative DNA/binding and activation-domain function is a major determinant of transcriptional regulation by activators in vivo.
Proc. Natl. Acad. Sci. USA
93:4311-4315 |
| 41. |
Uesugi, M.,
O. Nyanguile,
H. Lu,
A. J. Levine, and G. L. Verdine.
1997.
Induced alpha helix in the VP16 activation domain upon binding to a human TAF.
Science
277:1310-1313 |
| 42. | Van Hoy, M., K. K. Leuther, T. Kodadek, and S. A. Johnston. 1993. The acidic activation domains of the GCN4 and GAL4 proteins are not alpha-helical but form beta sheets. Cell 72:587-594[Medline]. |
| 43. |
Vashee, S., and T. Kodadek.
1995.
The activation domain of GAL4 protein mediates cooperative promoter binding with general transcription factors in vivo.
Proc. Natl. Acad. Sci. USA
92:10683-10687 |
| 44. | Venter, U., J. Svaren, J. Schmitz, A. Schmid, and W. Hörz. 1994. A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J. 13:4848-4855[Medline]. |
| 45. | Wu, R., R. J. Reece, and M. Ptashne. 1996. Quantitation of putative activator-target affinities predicts transcriptional activating potentials. EMBO J. 15:3951-3963[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»